UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+9.04%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$5.59B
AUM Growth
+$865M
(+18%)
Cap. Flow
+$450M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
66.42%
Holding
655
New
83
Increased
132
Reduced
97
Closed
122
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$800M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$386M |
| 3 |
NEWR
New Relic, Inc.
NEWR
|
$274M |
| 4 |
DEN
Denbury Inc.
DEN
|
$189M |
| 5 |
VMW
VMware, Inc
VMW
|
$172M |
Top Sells
Sector Composition
| 1 | Technology | 34.96% |
| 2 | Healthcare | 28.93% |
| 3 | Real Estate | 5.18% |
| 4 | Financials | 4.45% |
| 5 | Consumer Discretionary | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRBN
226
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $1.99M | 0.04% |
181,263
| – | – |
|
|
WEL
227
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $1.99M | 0.04% |
181,263
| – | – |
|
228
Cisco
CSCO
$263B
| $1.96M | 0.03% |
+36,506
| New | +$1.96M |
|
229
Match Group
MTCH
$9.24B
| $1.96M | 0.03% |
50,000
+25,000
| +100% | +$979K |
|
230
Establishment Labs
ESTA
$1.1B
| $1.96M | 0.03% |
39,902
+3,000
| +8% | +$147K |
|
|
DCPH
231
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.96M | 0.03% |
153,737
+77,000
| +100% | +$979K |
|
232
Mirum Pharmaceuticals
MIRM
$3.87B
| $1.93M | 0.03% |
61,000
+37,000
| +154% | +$1.17M |
|
233
Keros Therapeutics
KROS
$628M
| $1.92M | 0.03% |
60,341
+5,000
| +9% | +$159K |
|
234
Roivant Sciences
ROIV
$8.82B
| $1.92M | 0.03% |
164,211
-26,000
| -14% | -$304K |
|
235
TAL Education Group
TAL
$6.32B
| $1.92M | 0.03% |
+210,317
| New | +$1.92M |
|
236
MasTec
MTZ
$14B
| $1.89M | 0.03% |
26,295
+4,300
| +20% | +$309K |
|
237
Teva Pharmaceuticals
TEVA
$21.9B
| $1.89M | 0.03% |
+185,000
| New | +$1.89M |
|
|
NFYS
238
DELISTED
Enphys Acquisition Corp.
NFYS
| $1.87M | 0.03% |
178,033
| – | – |
|
|
HOLI
239
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $1.86M | 0.03% |
+93,570
| New | +$1.86M |
|
240
Kiniksa Pharmaceuticals
KNSA
$2.67B
| $1.85M | 0.03% |
106,423
-115,000
| -52% | -$2M |
|
241
MGM Resorts International
MGM
$9.9B
| $1.82M | 0.03% |
49,500
-359,902
| -88% | -$13.2M |
|
242
OrthoPediatrics
KIDS
$519M
| $1.8M | 0.03% |
56,219
+11,000
| +24% | +$352K |
|
243
Axsome Therapeutics
AXSM
$6.33B
| $1.8M | 0.03% |
25,735
| – | – |
|
244
Arcus Biosciences
RCUS
$1.19B
| $1.78M | 0.03% |
99,412
-5,000
| -5% | -$89.8K |
|
245
Trip.com Group
TCOM
$47.5B
| $1.75M | 0.03% |
50,000
-7,500
| -13% | -$262K |
|
246
BioCryst Pharmaceuticals
BCRX
$1.71B
| $1.71M | 0.03% |
241,820
+9,357
| +4% | +$66.2K |
|
247
X4 Pharmaceuticals
XFOR
$74.3M
| $1.7M | 0.03% |
52,000
+37,000
| +247% | +$1.21M |
|
248
UiPath
PATH
$6.22B
| $1.67M | 0.03% |
+97,500
| New | +$1.67M |
|
249
Xenon Pharmaceuticals
XENE
$2.94B
| $1.66M | 0.03% |
48,676
+10,000
| +26% | +$342K |
|
|
FNA
250
DELISTED
Paragon 28, Inc.
FNA
| $1.65M | 0.03% |
131,285
+45,000
| +52% | +$565K |
|